XT
LPCN icon

XTX Topco’s Lipocine LPCN Stock Holding History

XTX Topco’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$143K Buy
+17,923
New +$156K ﹤0.01% 2979
2022
Q2 		– Sell
-2,315
Closed -$54K – 983
2022
Q1 		$54K Buy
+2,315
New +$48.4K 0.02% 583
2021
Q4 		– Sell
-1,692
Closed -$31K – 862
2021
Q3 		$31K Buy
1,692
+474
+39% +$10.5K 0.01% 631
2021
Q2 		$29K Sell
1,218
-543
-31% -$12.8K 0.01% 749
2021
Q1 		$45K Buy
+1,761
New +$50.8K 0.02% 627

Other funds holding LPCN

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
SFCM
Seven Fleet Capital Management Mountain View, California $318M AUM
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

XTX Topco's LPCN Position: Q1 2026 in Review

XTX Topco opened a new position in Lipocine (LPCN) in Q1 2026: 17,923 shares worth $143K. The stake represents ﹤0.01% of the portfolio and ranks #2979 among its holdings. This is a return to the name: XTX Topco previously reported a position in LPCN as recently as Q1 2022.

XTX Topco first reported a position in LPCN in Q1 2021 and has held it in 5 quarters since. 47 funds tracked by Wall St. Rank hold LPCN as of Q1 2026.

  • XTX Topco held 17,923 shares of Lipocine worth $143K as of Q1 2026.
  • Lipocine was a new XTX Topco position in Q1 2026.
  • Lipocine made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #2979 holding.
  • XTX Topco first reported a position in Lipocine in Q1 2021 and has held it in 5 quarters since.
  • 47 funds tracked by Wall St. Rank held Lipocine as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.